Christiane Bieber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christiane Bieber has a total of 246 co-authors. Here are the top co-authors by number of shared publications:
Wolfgang Eich
Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg
13 shared publicationsKathrin Gschwendtner
Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg
5 shared publicationsKlaus Blumenstiel
University of Heidelberg, Department of Psychosomatic and General Internal Medicine, Heidelberg, Germany
4 shared publicationsMechthild Hartmann
Department of Psychosomatic and General Internal Medicine, Centre for Psychosocial Medicine, University of Heidelberg, Heidelberg, Germany
4 shared publicationsNicole Müller
Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg
4 shared publicationsJennifer Nicolai
Department of General Internal Medicine and Psychosomatics, Center for Psychosocial Medicine, Heidelberg University Hospital, Thibautstraße 4, 69115, Heidelberg, Germany
3 shared publications
Latest Publications
- 14 June 2024
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 121 (12) , 385-392
An online decision aid for patients with metastatic melanoma—results of the randomized controlled trial „PEF-Immun“
Background: Treatment decisions in metastatic melanoma (MM) are highly dependent on patient preferences and require the patients' involvement. The complexity of treatment options with their individual advantages and disadvantages is often overwhelming. We therefore developed an online patient decision aid (PtDA) to facilitate shared decision making (SDM). Methods: To evaluate the PtDA we conducted a two-armed, two- center, prospective, open randomized controlled trial with MM patients who were facing a decision about first-line treatment. The patients were allotted randomly in a 1:1 ratio to an intervention group (IG) with access to the PtDA before discussion with a physician or to a control group (CG) without access to the PtDA. The primary endpoint was knowledge about the options for first-line treatment (multiple-choice test, 10 items, range 0-40 points). The secondary endpoints were the SDM (third-party ratings of audio recordings of the treatment discussions) and satisfaction with the decision at the follow-up visit. Results: Of the 128 randomized patients, 120 completed the baseline questionnaire and were analyzed (59% male, median age 66 years). The primary endpoint, i.e., the mean difference in knowledge after discussion with a physician, differed significantly between the IG and the CG (-3.22, 95% CI [-6.32; -0.12], p = 0.042). No differences were found for the secondary endpoints, SDM and satisfaction with the decision. The patients in the IG rated the PtDA as very useful. Conclusion: The PtDA improved the knowledge of patients with MM about the options for treatment. Both groups were highly satisfied with their treatment decisions. However, additional physician training seems necessary to promote SDM.
- 14 June 2024
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 121 (12) , 385-392
An online decision aid for patients with metastatic melanoma—results of the randomized controlled trial „PEF-Immun“
Background: Treatment decisions in metastatic melanoma (MM) are highly dependent on patient preferences and require the patients' involvement. The complexity of treatment options with their individual advantages and disadvantages is often overwhelming. We therefore developed an online patient decision aid (PtDA) to facilitate shared decision making (SDM). Methods: To evaluate the PtDA we conducted a two-armed, two- center, prospective, open randomized controlled trial with MM patients who were facing a decision about first-line treatment. The patients were allotted randomly in a 1:1 ratio to an intervention group (IG) with access to the PtDA before discussion with a physician or to a control group (CG) without access to the PtDA. The primary endpoint was knowledge about the options for first-line treatment (multiple-choice test, 10 items, range 0-40 points). The secondary endpoints were the SDM (third-party ratings of audio recordings of the treatment discussions) and satisfaction with the decision at the follow-up visit. Results: Of the 128 randomized patients, 120 completed the baseline questionnaire and were analyzed (59% male, median age 66 years). The primary endpoint, i.e., the mean difference in knowledge after discussion with a physician, differed significantly between the IG and the CG (-3.22, 95% CI [-6.32; -0.12], p = 0.042). No differences were found for the secondary endpoints, SDM and satisfaction with the decision. The patients in the IG rated the PtDA as very useful. Conclusion: The PtDA improved the knowledge of patients with MM about the options for treatment. Both groups were highly satisfied with their treatment decisions. However, additional physician training seems necessary to promote SDM.
- Open Access
- 20 April 2021
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-11
Development and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial
Background: Patients with metastatic melanoma and their physicians are confronted with a complex decision regarding first-line therapy. Risks and benefits vary considerably between various treatment options. With this in mind, we aim to develop and evaluate a patient decision aid (PtDA) to inform patients about the risks and benefits of treatment options, namely, immunotherapy as monotherapy, immunotherapy as combination therapy, and treatment with BRAF/MEK inhibitors. We aim to test whether the use of this PtDA before medical consultation will increase patients’ knowledge of treatment options and thus promote shared decision-making (SDM) and patient decision satisfaction. Methods: In total, 128 patients with metastatic melanoma from two German cancer centers will be randomized to the intervention group (IG), receiving access to the PtDA before medical consultation, or the control group (CG), receiving treatment as usual (TAU), i.e., medical consultation alone. There will be three major assessment points (before intervention, T0; after intervention, T1; and 3 months after intervention, T2). The main outcome is the patient’s knowledge of their treatment options, measured by a self-developed, piloted multiple-choice test at T1. Secondary outcome measures will include the extent of SDM during medical consultation, assessed by Observer OPTION 5, and patient decision satisfaction, assessed by the Satisfaction with Decision Scale (SwD), at T1 and T2. Discussion: This trial will assess the effectiveness of a developed PtDA to enhance patient knowledge of treatment options for metastatic melanoma, SDM, and patient decision satisfaction. If the efficacy can be proven, the PtDA will be implemented nationwide in Germany to close a relevant gap in the education and care of patients with metastatic melanoma. Trial registration: ClinicalTrials.gov NCT04240717. Registered on 27 January 2020
- 20 April 2021
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-11
Open AccessDevelopment and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial
Background: Patients with metastatic melanoma and their physicians are confronted with a complex decision regarding first-line therapy. Risks and benefits vary considerably between various treatment options. With this in mind, we aim to develop and evaluate a patient decision aid (PtDA) to inform patients about the risks and benefits of treatment options, namely, immunotherapy as monotherapy, immunotherapy as combination therapy, and treatment with BRAF/MEK inhibitors. We aim to test whether the use of this PtDA before medical consultation will increase patients’ knowledge of treatment options and thus promote shared decision-making (SDM) and patient decision satisfaction. Methods: In total, 128 patients with metastatic melanoma from two German cancer centers will be randomized to the intervention group (IG), receiving access to the PtDA before medical consultation, or the control group (CG), receiving treatment as usual (TAU), i.e., medical consultation alone. There will be three major assessment points (before intervention, T0; after intervention, T1; and 3 months after intervention, T2). The main outcome is the patient’s knowledge of their treatment options, measured by a self-developed, piloted multiple-choice test at T1. Secondary outcome measures will include the extent of SDM during medical consultation, assessed by Observer OPTION 5, and patient decision satisfaction, assessed by the Satisfaction with Decision Scale (SwD), at T1 and T2. Discussion: This trial will assess the effectiveness of a developed PtDA to enhance patient knowledge of treatment options for metastatic melanoma, SDM, and patient decision satisfaction. If the efficacy can be proven, the PtDA will be implemented nationwide in Germany to close a relevant gap in the education and care of patients with metastatic melanoma. Trial registration: ClinicalTrials.gov NCT04240717. Registered on 27 January 2020
- 1 December 2020
- Published by Psychosozial-Verlag GmbH and Co. KG in Balint Journal
- Vol. 21 (04) , 111-122
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
Zusammenfassung: Viele Akteure des Gesundheitssystems verstehen das Konzept der Partizipativen Entscheidungsfindung (PEF) als besonders günstige Form der Arzt-Patient-Interaktion. Der Artikel grenzt die PEF ab gegen weitere Modelle der Arzt-Patient-Interaktion, bespricht Anwendungsbereiche und Strategien sowie Hilfsmaterialien zur Umsetzung im individuellen Arzt-Patient-Kontakt. Effekte der PEF für Patienten und für Behandler werden aufgezeigt.
- 1 December 2020
- Published by Psychosozial-Verlag GmbH and Co. KG in Balint Journal
- Vol. 21 (04) , 111-122
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
Zusammenfassung: Viele Akteure des Gesundheitssystems verstehen das Konzept der Partizipativen Entscheidungsfindung (PEF) als besonders günstige Form der Arzt-Patient-Interaktion. Der Artikel grenzt die PEF ab gegen weitere Modelle der Arzt-Patient-Interaktion, bespricht Anwendungsbereiche und Strategien sowie Hilfsmaterialien zur Umsetzung im individuellen Arzt-Patient-Kontakt. Effekte der PEF für Patienten und für Behandler werden aufgezeigt.
- 29 August 2019
- Published by Georg Thieme Verlag KG in Diabetologie und Stoffwechsel
- Vol. 14 (04) , 277-291
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
The article provides an overview on Shared Decision Making (SDM), which is considered as the ideal form of physician-patient-interaction by many stakeholders of the health care system. SDM is distinguished from other models of physician-patient-interaction such as the paternalistic model and the information model. Besides the degree of acceptance of SDM in the general population and among physicians, barriers for its implementation will be reported. Indications for SDM as well as strategies and support material for its use in individual consultations will be discussed and illustrated by an oncological case study. Effects of SDM for patients as well as for clinicians will be highlighted. After background information on origins of SDM, its significance with regard to health policy in Germany is discussed.
- 29 August 2019
- Published by Georg Thieme Verlag KG in Diabetologie und Stoffwechsel
- Vol. 14 (04) , 277-291
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
The article provides an overview on Shared Decision Making (SDM), which is considered as the ideal form of physician-patient-interaction by many stakeholders of the health care system. SDM is distinguished from other models of physician-patient-interaction such as the paternalistic model and the information model. Besides the degree of acceptance of SDM in the general population and among physicians, barriers for its implementation will be reported. Indications for SDM as well as strategies and support material for its use in individual consultations will be discussed and illustrated by an oncological case study. Effects of SDM for patients as well as for clinicians will be highlighted. After background information on origins of SDM, its significance with regard to health policy in Germany is discussed.
- Open Access
- 7 January 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-11
Study protocol of a randomized controlled trial on two new dissemination strategies for a brief, shared-decision-making (SDM) training for oncologists: web-based interactive SDM online-training versus individualized context-based SDM face-to-face training
Oncological patients often feel left out of important treatment decisions. However, when physicians engage them in shared decision-making (SDM), patients benefit in many ways and the situation is improved. SDM can effectively be taught to physicians, but participation barriers for SDM physician group trainings are high, making it hard to convince physicians to participate. With this in mind, we aim to develop and evaluate two new dissemination strategies for a brief, SDM training program based upon a proven SDM group-training concept: an individualized context-based SDM face-to-face training (IG I) and a web-based interactive SDM online training (IG II). We aim to analyze which improvements can be achieved by IG I and II compared to a control group (CG) in physician SDM competence and performance as well as the impact on the physician-patient relationship. Furthermore, we analyze differences in satisfaction concerning the two dissemination strategies by means of a training evaluation. We examine – based on a three-armed randomized controlled trial (IG I, IG II, CG) – the effectiveness of two new dissemination strategies for a SDM training program compared to a CG receiving no SDM training (voluntary access to SDM training as an incentive for participation after completion of the study). We aim to include 162 physicians randomized to one of the three arms. There will be two assessment points in time (before intervention: T0 and post-training: T1). The main outcome is the SDM competence of physicians as measured by an established observational assessment rating system (OPTION-12) by means of consultations with Standardized Patients. Standardized Patients are individuals trained to act as “real” patients. Secondary outcome measures are the SDM performance (SDM-Q-9) and the Questionnaire on the Quality of Physician-Patient-Interaction (QQPPI) both rated by Standardized Patients as well as the physicians’ training evaluation. This trial will assess the effectiveness and acceptability of two new dissemination strategies for a brief, SDM training program for physicians. Opportunities and challenges regarding implementation in daily routines will be discussed. ClinicalTrials.gov, Identifier: NCT02674360 . Prospectively registered on 4 February 2016.
- 7 January 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 1-11
Open AccessStudy protocol of a randomized controlled trial on two new dissemination strategies for a brief, shared-decision-making (SDM) training for oncologists: web-based interactive SDM online-training versus individualized context-based SDM face-to-face training
Oncological patients often feel left out of important treatment decisions. However, when physicians engage them in shared decision-making (SDM), patients benefit in many ways and the situation is improved. SDM can effectively be taught to physicians, but participation barriers for SDM physician group trainings are high, making it hard to convince physicians to participate. With this in mind, we aim to develop and evaluate two new dissemination strategies for a brief, SDM training program based upon a proven SDM group-training concept: an individualized context-based SDM face-to-face training (IG I) and a web-based interactive SDM online training (IG II). We aim to analyze which improvements can be achieved by IG I and II compared to a control group (CG) in physician SDM competence and performance as well as the impact on the physician-patient relationship. Furthermore, we analyze differences in satisfaction concerning the two dissemination strategies by means of a training evaluation. We examine – based on a three-armed randomized controlled trial (IG I, IG II, CG) – the effectiveness of two new dissemination strategies for a SDM training program compared to a CG receiving no SDM training (voluntary access to SDM training as an incentive for participation after completion of the study). We aim to include 162 physicians randomized to one of the three arms. There will be two assessment points in time (before intervention: T0 and post-training: T1). The main outcome is the SDM competence of physicians as measured by an established observational assessment rating system (OPTION-12) by means of consultations with Standardized Patients. Standardized Patients are individuals trained to act as “real” patients. Secondary outcome measures are the SDM performance (SDM-Q-9) and the Questionnaire on the Quality of Physician-Patient-Interaction (QQPPI) both rated by Standardized Patients as well as the physicians’ training evaluation. This trial will assess the effectiveness and acceptability of two new dissemination strategies for a brief, SDM training program for physicians. Opportunities and challenges regarding implementation in daily routines will be discussed. ClinicalTrials.gov, Identifier: NCT02674360 . Prospectively registered on 4 February 2016.
- 11 June 2018
- Published by Georg Thieme Verlag KG in Der Nuklearmediziner
- Vol. 41 (02) , 162-177
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
Viele Akteure des Gesundheitssystems verstehen das Konzept der Partizipativen Entscheidungsfindung (PEF) als besonders günstige Form der Arzt-Patient-Interaktion. Der Artikel grenzt die PEF ab gegen weitere Modelle der Arzt-Patient-Interaktion, bespricht Anwendungsbereiche und Strategien sowie Hilfsmaterialien zur Umsetzung im individuellen Arzt-Patient-Kontakt. Effekte der PEF für Patienten und für Behandler werden aufgezeigt.
- 11 June 2018
- Published by Georg Thieme Verlag KG in Der Nuklearmediziner
- Vol. 41 (02) , 162-177
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
Viele Akteure des Gesundheitssystems verstehen das Konzept der Partizipativen Entscheidungsfindung (PEF) als besonders günstige Form der Arzt-Patient-Interaktion. Der Artikel grenzt die PEF ab gegen weitere Modelle der Arzt-Patient-Interaktion, bespricht Anwendungsbereiche und Strategien sowie Hilfsmaterialien zur Umsetzung im individuellen Arzt-Patient-Kontakt. Effekte der PEF für Patienten und für Behandler werden aufgezeigt.
- 15 December 2017
- Published by Georg Thieme Verlag KG in Zahnmedizin up2date
- Vol. 11 (06) , 619-634
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
Viele Akteure des Gesundheitssystems verstehen das Konzept der Partizipativen Entscheidungsfindung (PEF) als besonders günstige Form der Arzt-Patient-Interaktion. Der Artikel grenzt die PEF ab gegen weitere Modelle der Arzt-Patient-Interaktion, bespricht Anwendungsbereiche und Strategien sowie Hilfsmaterialien zur Umsetzung im individuellen Arzt-Patient-Kontakt. Effekte der PEF für Patienten und für Behandler werden aufgezeigt.
- 15 December 2017
- Published by Georg Thieme Verlag KG in Zahnmedizin up2date
- Vol. 11 (06) , 619-634
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
Viele Akteure des Gesundheitssystems verstehen das Konzept der Partizipativen Entscheidungsfindung (PEF) als besonders günstige Form der Arzt-Patient-Interaktion. Der Artikel grenzt die PEF ab gegen weitere Modelle der Arzt-Patient-Interaktion, bespricht Anwendungsbereiche und Strategien sowie Hilfsmaterialien zur Umsetzung im individuellen Arzt-Patient-Kontakt. Effekte der PEF für Patienten und für Behandler werden aufgezeigt.
- 1 November 2017
- Published by Elsevier in Patient Education and Counseling
- Vol. 100 (11) , 1967-1968
The perspective of the person in healthcare: Listening to and engaging persons in healthcare
- 1 November 2017
- Published by Elsevier in Patient Education and Counseling
- Vol. 100 (11) , 1967-1968
The perspective of the person in healthcare: Listening to and engaging persons in healthcare
- 9 June 2017
- Published by Georg Thieme Verlag KG in Die Rehabilitation
- Vol. 56 (03) , 198-213
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
Zusammenfassung: Der Artikel gibt einen Überblick über das Konzept der Partizipativen Entscheidungsfindung (PEF), das von vielen Akteuren des Gesundheitssystems als besonders günstige Form der Arzt-Patient-Interaktion verstanden wird. Die PEF wird abgegrenzt gegen weitere Modelle der Arzt-Patient-Interaktion wie das Paternalistische Modell und das Informationsmodell. Neben den Akzeptanzwerten von PEF in der Bevölkerung und unter Ärzten wird auch auf mögliche Barrieren in der Umsetzung eingegangen. Anwendungsbereiche für die PEF werden besprochen und Strategien sowie Hilfsmaterialien zur Umsetzung im individuellen Arzt-Patient-Kontakt dargestellt und anhand eines onkologischen Fallbeispiels vertieft. Effekte der PEF für Patienten und für Behandler werden aufgezeigt. Nach Eingehen auf wichtige Quellen von PEF erfolgt die Einordnung vor dem aktuellen gesundheitspolitischen Hintergrund in Deutschland.
- 9 June 2017
- Published by Georg Thieme Verlag KG in Die Rehabilitation
- Vol. 56 (03) , 198-213
Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team
Zusammenfassung: Der Artikel gibt einen Überblick über das Konzept der Partizipativen Entscheidungsfindung (PEF), das von vielen Akteuren des Gesundheitssystems als besonders günstige Form der Arzt-Patient-Interaktion verstanden wird. Die PEF wird abgegrenzt gegen weitere Modelle der Arzt-Patient-Interaktion wie das Paternalistische Modell und das Informationsmodell. Neben den Akzeptanzwerten von PEF in der Bevölkerung und unter Ärzten wird auch auf mögliche Barrieren in der Umsetzung eingegangen. Anwendungsbereiche für die PEF werden besprochen und Strategien sowie Hilfsmaterialien zur Umsetzung im individuellen Arzt-Patient-Kontakt dargestellt und anhand eines onkologischen Fallbeispiels vertieft. Effekte der PEF für Patienten und für Behandler werden aufgezeigt. Nach Eingehen auf wichtige Quellen von PEF erfolgt die Einordnung vor dem aktuellen gesundheitspolitischen Hintergrund in Deutschland.
- Open Access
- 13 December 2016
- Published by Springer Nature in Journal of Cancer Education
- Vol. 33 (3) , 708-715
How Does a Shared Decision-Making (SDM) Intervention for Oncologists Affect Participation Style and Preference Matching in Patients with Breast and Colon Cancer?
The aims of this study are to assess patients’ preferred and perceived decision-making roles and preference matching in a sample of German breast and colon cancer patients and to investigate how a shared decision-making (SDM) intervention for oncologists influences patients’ preferred and perceived decision-making roles and the attainment of preference matches. This study is a post hoc analysis of a randomised controlled trial (RCT) on the effects of an SDM intervention. The SDM intervention was a 12-h SDM training program for physicians in combination with decision board use. For this study, we analysed a subgroup of 107 breast and colon cancer patients faced with serious treatment decisions who provided data on specific questionnaires with regard to their preferred and perceived decision-making roles (passive, SDM or active). Patients filled in questionnaires immediately following a decision-relevant consultation (t1) with their oncologist. Eleven of these patients’ 27 treating oncologists had received the SDM intervention within the RCT. A majority of cancer patients (60%) preferred SDM. A match between preferred and perceived decision-making roles was reached for 72% of patients. The patients treated by SDM-trained physicians perceived greater autonomy in their decision making (p < 0.05) with more patients perceiving SDM or an active role, but their preference matching was not influenced. A SDM intervention for oncologists boosted patient autonomy but did not improve preference matching. This highlights the already well-known reluctance of physicians to engage in explicit role clarification. Trial Registration: German Clinical Trials Register DRKS00000539; Funding Source: German Cancer Aid.
- 13 December 2016
- Published by Springer Nature in Journal of Cancer Education
- Vol. 33 (3) , 708-715
Open AccessHow Does a Shared Decision-Making (SDM) Intervention for Oncologists Affect Participation Style and Preference Matching in Patients with Breast and Colon Cancer?
The aims of this study are to assess patients’ preferred and perceived decision-making roles and preference matching in a sample of German breast and colon cancer patients and to investigate how a shared decision-making (SDM) intervention for oncologists influences patients’ preferred and perceived decision-making roles and the attainment of preference matches. This study is a post hoc analysis of a randomised controlled trial (RCT) on the effects of an SDM intervention. The SDM intervention was a 12-h SDM training program for physicians in combination with decision board use. For this study, we analysed a subgroup of 107 breast and colon cancer patients faced with serious treatment decisions who provided data on specific questionnaires with regard to their preferred and perceived decision-making roles (passive, SDM or active). Patients filled in questionnaires immediately following a decision-relevant consultation (t1) with their oncologist. Eleven of these patients’ 27 treating oncologists had received the SDM intervention within the RCT. A majority of cancer patients (60%) preferred SDM. A match between preferred and perceived decision-making roles was reached for 72% of patients. The patients treated by SDM-trained physicians perceived greater autonomy in their decision making (p < 0.05) with more patients perceiving SDM or an active role, but their preference matching was not influenced. A SDM intervention for oncologists boosted patient autonomy but did not improve preference matching. This highlights the already well-known reluctance of physicians to engage in explicit role clarification. Trial Registration: German Clinical Trials Register DRKS00000539; Funding Source: German Cancer Aid.